Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report

Volume 20, Issue 1, December 2024 .
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research